6/26/2024
Aspivix and Xemperia both receive support from FIT
The Foundation for Technological Innovation is pleased to announce two new loans to Aspivix and Xemperia. Aspivix has been awarded a Tech Growth loan of CHF 500,000 for its non-traumatic device for all gynaecological procedures, while Xemperia, which offers blood test for the detection of breast cancer, has been granted a Tech Seed loan of CHF 100,000.